Javascript must be enabled to continue!
Development and Evaluation of an Algorithm to Detect COPD Through an Intelligent Device
View through CrossRef
Abstract
Rationale:Chronic obstructive pulmonary disease (COPD) is one of the most common respiratory diseases. Early detection and treatment are critical to prevent the deterioration of COPD. In this study, we aim to establishment and evaluation an algorithm that can detect COPD from physiological parameters and audio data which are collected by a wearable device.Methods: Participants were instructed to use HUAWEI smart wearable devices to collect physiological data, including oxygen saturation, heart rate, respiratory rate, and cough sounds. The collected data served as measurement inputs. To evaluate the accuracy of the HUAWEI smart wearable device and its associated algorithms for lung function assessment and COPD screening, a comparative analysis was conducted. This analysis used the results of medical spirometers and the diagnoses of hospital respiratory specialists as the gold standard for assessing lung function and diagnosing COPD.Results:400 subjects (236 males,164 females; 200 with stable COPD and 200 without COPD) were recruited for algorithm development, among COPD patients, age distribution was≤50 years(30), 51-65years(73), and > 65years(97), with GOLD stages 1(58), 2(102), and 3+4(40). A further 400 subjects (240 males, 160 females;200 with COPD and 200 without COPD) were recruited for testing the algorithm.The overall mean age was 57.8 years, mean BMI was 24.7kg/m2, and mean FEV1/FVC ratio was 0.69.Pulmonary Function results showed an MAE of 6.6% for FEV1/FVC and 10.0% for FVC.COPD screening achieved 80.8% accuracy,80.0% sensitivity and 81.5% specificity.Conclusions:The test results based on Huawei's smart wearable device and its accompanying lung function assessment and COPD screening algorithms are highly consistent with the diagnostic results of medical spirometers and professional doctors, and are effective for lung function assessment and COPD screening.
Oxford University Press (OUP)
Title: Development and Evaluation of an Algorithm to Detect COPD Through an Intelligent Device
Description:
Abstract
Rationale:Chronic obstructive pulmonary disease (COPD) is one of the most common respiratory diseases.
Early detection and treatment are critical to prevent the deterioration of COPD.
In this study, we aim to establishment and evaluation an algorithm that can detect COPD from physiological parameters and audio data which are collected by a wearable device.
Methods: Participants were instructed to use HUAWEI smart wearable devices to collect physiological data, including oxygen saturation, heart rate, respiratory rate, and cough sounds.
The collected data served as measurement inputs.
To evaluate the accuracy of the HUAWEI smart wearable device and its associated algorithms for lung function assessment and COPD screening, a comparative analysis was conducted.
This analysis used the results of medical spirometers and the diagnoses of hospital respiratory specialists as the gold standard for assessing lung function and diagnosing COPD.
Results:400 subjects (236 males,164 females; 200 with stable COPD and 200 without COPD) were recruited for algorithm development, among COPD patients, age distribution was≤50 years(30), 51-65years(73), and > 65years(97), with GOLD stages 1(58), 2(102), and 3+4(40).
A further 400 subjects (240 males, 160 females;200 with COPD and 200 without COPD) were recruited for testing the algorithm.
The overall mean age was 57.
8 years, mean BMI was 24.
7kg/m2, and mean FEV1/FVC ratio was 0.
69.
Pulmonary Function results showed an MAE of 6.
6% for FEV1/FVC and 10.
0% for FVC.
COPD screening achieved 80.
8% accuracy,80.
0% sensitivity and 81.
5% specificity.
Conclusions:The test results based on Huawei's smart wearable device and its accompanying lung function assessment and COPD screening algorithms are highly consistent with the diagnostic results of medical spirometers and professional doctors, and are effective for lung function assessment and COPD screening.
Related Results
Cancer development in COPD patients: retrospective analysis of the National Health Insurance Service-National Sample Cohort in Korea
Cancer development in COPD patients: retrospective analysis of the National Health Insurance Service-National Sample Cohort in Korea
Abstract
Background: COPD is a well-known risk factor for lung cancer, independent of smoking behavior. By investigating the retrospective National Health Insurance Service...
Cancer development in COPD patients: retrospective analysis of the National Health Insurance Service-National Sample Cohort in Korea
Cancer development in COPD patients: retrospective analysis of the National Health Insurance Service-National Sample Cohort in Korea
Abstract
Background: COPD is a well-known risk factor for lung cancer, independent of smoking behavior. By investigating the retrospective National Health Insurance Service...
Cancer development in COPD patients: retrospective analysis of the National Health Insurance Service-National Sample Cohort in Korea
Cancer development in COPD patients: retrospective analysis of the National Health Insurance Service-National Sample Cohort in Korea
Abstract
Background: COPD is a well-known risk factor for lung cancer, independent of smoking behavior. By investigating the retrospective National Health Insurance Service...
National trends in utilization and outcomes of percutaneous coronary intervention (PCI) among patients with and without COPD in Spain (2001-2011)
National trends in utilization and outcomes of percutaneous coronary intervention (PCI) among patients with and without COPD in Spain (2001-2011)
Background: COPD is associated with a high risk of death due to coronary artery disease (CAD). Patients with COPD suffering from CAD are frequently treated with revascularization p...
Comparison of Functional Capacity and Symptoms of COPD Patients with and without Pulmonary Hypertension
Comparison of Functional Capacity and Symptoms of COPD Patients with and without Pulmonary Hypertension
Objective: Pulmonary hypertension (PH) is a common complication of chronic obstructive pulmonary disease (COPD) associated with a decrease in the survival rate of patients with COP...
Plasma short-chain fatty acids are associated with COPD and COPD phenotypes
Plasma short-chain fatty acids are associated with COPD and COPD phenotypes
Abstract
Background and aim
Short-chain fatty acids (SCFAs) are metabolites largely produced by the gut microbiota, excep...
Analysis of the association of ANO3/MUC15, COL4A4, RRBP1, and KLK1 polymorphisms with COPD susceptibility in the Kashi population
Analysis of the association of ANO3/MUC15, COL4A4, RRBP1, and KLK1 polymorphisms with COPD susceptibility in the Kashi population
Abstract
Objective
Chronic obstructive pulmonary disease (COPD) is a complex, multifactorial, polygenic disease. The rate of occurrence of COPD in t...
Assessment of COPD Overdiagnosis as an Important Factor in COPD Readmission
Assessment of COPD Overdiagnosis as an Important Factor in COPD Readmission
Introduction: The Hospital Readmission Reduction Program (HRRP) was established in 2012 to improve health care by linking payment to the quality of hospital care. Readmission is co...

